癌症研究档案

  • 国际标准期刊号: 2254-6081
  • 期刊 h 指数: 13
  • 期刊引用分数: 3.58
  • 期刊影响因子: 3.12
索引于
  • 中国知网(CNKI)
  • 引用因子
  • OCLC-WorldCat
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • 谷歌学术
  • 秘密搜索引擎实验室
分享此页面

抽象的

Novel Strategy for Colorectal Liver Cancer- Hepatocyte Growth Factor EstimationConcept

Gagan Chhabra, Neelu Puri

Colorectal disease is the third most regular epithelial threataround the world. Sooner or later in the characteristiccourse of patients with this illness, up to half will fostermetastasis to the liver, i.e., Colorectal Liver Metastasis(CLM), which addresses quite possibly the most well-knowndangers to life. An assortment of remedial ways to deal withtreat this hazardous sickness have been endeavored thathave now brought about the acknowledgment of a forcefultechnique in any event, for cutting edge cases. Be that as itmay, the careful signs for resection of coordinatedmetastases and the ideal planning of hepatectomy are asyet dubious and generally discussed. In the current survey,chemotherapeutic procedures including as of late createdsystems or potentially hepatectomy are proposed puttogether with respect to the clinical information as well ason natural ideas in which chemotherapy causes hepatocytedevelopment factor (HGF)- related epithelial mesenchymalprogress (EMT).